Comparative split-mouth study of the anesthetic efficacy of 4% articaine versus 0.5% bupivacaine in impacted mandibular third molar extraction by Pellicer Chover, Hilario et al.
e66
J Clin Exp Dent. 2013;5(2):e66-71. Comparative study of articaine and bupivacaine.
Journal section: Oral Surgery                           
Publication Types: Research
Comparative split-mouth study of the anesthetic efficacy of 4% articaine 
versus 0.5% bupivacaine in impacted mandibular third molar extraction 
Hilario Pellicer-Chover 1, Juan Cervera-Ballester 1, José María Sanchis-Bielsa 2, María A. Peñarrocha-Diago 3, 
Miguel Peñarrocha-Diago 4, Berta García-Mira 3
1 Student of the Master’s Degree in Surgery and Implant Dentistry, Faculty of Medicine and Dentistry, University of Valencia, 
Spain.
2 Associate Lecturer in Oral Surgery, Faculty of Medicine and Dentistry, Adjunct Doctor at Valencia University General Hospital 
Dental Service, Spain. 
3 Associate Lecturer in Oral Surgery, Faculty of Medicine and Dentistry, University of Valencia, Spain. Lecturer on the Master’s 
Degree in Surgery and Implant Dentistry.
4 Professor of Oral Surgery and Chairman of the Master’s Degree in Surgery and Implant Dentistry, Faculty of Medicine and Den-
tistry, University of Valencia, Spain.
Correspondence: 
Clínicas odontológicas
Gascó Oliag 1
46021- Valencia,Spain.
E-mail address: berta.garcia@uv.es
Received: 03/05/2012
Accepted: 23/02/2013
Abstract 
Objective: The purpose of this study was to compare the clinical efficacy of articaine at 4% (epinephrine 1:100,000) 
with bupivacaine at 0.5% (epinephrine 1:200,000) for surgical extraction of impacted mandibular third molars. 
Study Design: This was a randomized, double blind, split-mouth, clinical trial. Thirty-six patients took part and 
underwent extraction of 72 lower third molars. The variables studied were: anesthetic latency time, intra-operative 
bleeding, anesthetic quality, hemodynamic changes during the surgical intervention, anesthetic duration in the soft 
tissues, post-operative analgesia and post-operative pain at 2, 6, 12 and 24 hours using a visual analogue scale, as 
well as any need for additional rescue medication. 
Results: Latency time was 2.0 minutes for articaine and 3.1 minutes for bupivacaine, with statistically significant 
difference (p<0.05). Bleeding was greater when bupivacaine was used (p<0.05) and anesthetic quality was greater 
with articaine (p<0.05). The duration of soft tissue anesthesia was longer with bupivacaine (p<0.05). Differences 
in post-operative analgesia, haemodynamic changes, post-operative pain and the quantity of rescue medication 
consumed were not statistically significant (p>0.05).
Conclusions: Articaine showed greater clinical efficacy than bupivacaine, reducing latency time, bleeding, anesthe-
tic duration in the soft tissues and achieving higher anesthetic quality, requiring less reinforcement during surgery 
than bupivacaine. 
Key word: Articaine, bupivacaine, anesthetic efficacy, impacted mandibular third molar.
Pellicer-Chover H, Cervera-Ballester J, Sanchis-Bielsa JM, Peñarrocha-
Diago MA, Peñarrocha-Diago M, García-Mira B. Comparative split-
mouth study of the anesthetic efficacy of 4% articaine versus 0.5% 
bupivacaine in impacted mandibular third molar extraction. J Clin Exp 
Dent. 2013;5(2):e66-71.
http://www.medicinaoral.com/odo/volumenes/v5i2/jcedv5i2p66.pdf
Article Number: 50869                http://www.medicinaoral.com/odo/indice.htm
© Medicina Oral S. L. C.I.F. B 96689336 - eISSN: 1989-5488
eMail:  jced@jced.es
Indexed in:
Scopus
DOI® System
doi:10.4317/jced.50869
http://dx.doi.org/10.4317/jced.50869
e67
J Clin Exp Dent. 2013;5(2):e66-71. Comparative study of articaine and bupivacaine.
Introduction
Impacted lower third molar has a high rate of incidence, 
third molar extraction being the most frequent extraction 
performed in the oral cavity (1). It is associated with the 
appearance of very diverse pathologies such as pericoro-
nitis, caries on the distal face of the second lower molar 
and on the third molar, myofascial pain, certain types of 
cyst and odontogenic tumors and dental overcrowding 
(2). Pain, inflammation and post-operative trismus are 
the main symptoms following impacted lower third mo-
lar surgery (3, 4). The pain is more intense between three 
and five hours after extraction, as the local anesthetic 
wears off (5), and is generally controlled using analge-
sics or non-steroidal anti-inflammatory drugs (NSAIDs) 
taken orally (6).
The application of long-acting local anesthetics has been 
shown to reduce immediate post-operative pain (7, 8). 
Bupivacaine produces a slow return of sensation that is 
associated with the gradual onset of post-operative dis-
comfort (3). However, the long duration of anesthesia 
in the soft tissues is considered an unpleasant sensation 
for the patient (6, 9, 10). Its use is justified in surgery of 
long duration and post-operative periods with foreseea-
ble discomfort (11, 12).
Bupivacaine was developed in 1957 by Ekenstam, Eg-
ner and Pettersson and its clinical use was first described 
by Widman in 1964 (3, 4). It was introduced onto the 
market in 1984 and since then numerous studies have 
been published comparing it mainly with lidocaine (3, 4, 
6, 8, 13). The results of these trials suggest that bupiva-
caine was superior due to: similar latency time, four time 
greater strength, delay to the appearance and intensity of 
post-operative pain, a reduction to the use of analgesics 
and the minimal incidence of secondary effects.  
There is a wide variety of literature comparing different 
anesthetics, but only three (11, 14, 15) have compared 
bupivacaine with articaine for third molar extraction. 
The aim of the present study was to compare the clinical 
efficacy of articaine at 4% (epinephrine 1:100,000) with 
bupivacaine at 0.5% (epinephrine 1:200,000) for the sur-
gical extraction of impacted mandibular third molars. 
Material and Methods
-Sample Selection
This randomized double blind, split-mouth, clinical trial 
was performed at the Oral Surgery Unit of a University 
Clinic. All patients gave their informed consent in wri-
ting. The study protocol was approved by the University 
of Valencia Faculty of Dentistry’s ethics committee. Of a 
total of 220 patients requiring impacted lower third mo-
lar extraction between November 2009 and May 2010, 
the patients selected were all adults requiring bilateral 
impacted lower third molar extration with similar levels 
of surgical difficulty according to the Alemany-Martinez 
et al. scale (16) (Table 1).
Exclusion criteria were: patients presenting systemic di-
seases, patients in pharmacological treatment (excepting 
oral contraceptives) and patients allergic to the drugs 
used in the trial. Having completed a study protocol for 
each subject, 20 were discarded as they did not meet the 
criteria. Finally, 36 patients took part (12 men and 24 
women), with an average age of 23.1 ± 6 years (range 
18-37).
-Surgical Procedure 
The articaine and bupivacaine carpules (1.8 ml) were 
marked as “1” or “2” by an individual unrelated to the 
study. The local anesthetic used and the side of the inter-
vention were allotted randomly using a predefined ran-
dom numbers table and enclosed in envelopes. 
At the first intervention, patients received 4% articaine 
with 1:100,000 epinephrine (Ultracaine, Inibsa, Barce-
lona, Spain) or 0.5% bupivacaine with 1:200,000 epine-
phrine (Inibsacain Plus®, Inibsa, Barcelona, Spain). At 
the second intervention, the anesthetic not used at the 
Spatial Relation Depth Available Space
1 Mesioangular 1 Level A 1 Class I
2 Horizontal/transverse 2 Level B 2 Class II
3 Vertical 3 Level C 3 Class III
4 Distoangular
Spatial Relation 
Third molar position in relation to the second molar long axis. 
Depth
Level A: Highest part of third molar at the same level or above the plane of second molar occlusal surface. Level B: Highest part of third 
molar between occlusal line and cervical line of the second molar. Level C: Highest part of third molar at same level or below the plane of 
the second molar cervical line. 
Available Space 
Class I: The space between the distal surface of the second molar and the ascending mandibular ramus is greater than the mesiodistal dia-
meter of the third molar. Class II: The space between the distal surface of the second molar and the ascending mandibular ramus is less than 
the mesiodistal diameter of the third molar. Class III: The third molar is partially or totally inside the ascending mandibular ramus. 
Level of Difficulty
3-4 minimum; 5-6, moderate; 7-10 very difficult.
Table 1.Table showing surgical difficulty in impacted lower third molar extraction as classified by Alemany-Martínez et al. (16).
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tive variables. When the distribution of variables did not 
fulfill the t-test criteria, the Wilcoxon non-parametric 
test was used.
The relation between surgical time and post-operative 
pain was analyzed using the Pearson correlation coeffi-
cient. In the case of category variables – bleeding and 
anesthetic quality – the McNemar-Bowker non-parame-
tric test was applied to determine differences between 
the two types of anesthetic. 
ANOVA was performed on repeated measurements to 
analyze the effect of the type of anesthesia at each point 
during the surgical procedure (base-line, anesthesia, in-
cision, flap elevation, ostectomy, extraction and suture) 
on haemodynamic variables, as well as time (2, 6, 12 
and 24 hours) and post-operative pain.
Results
The most common reason for extraction was perico-
ronitis antecedents (47.2%), followed by prophylactic 
reasons (27.8%), orthodontic requirements (16.7%) and 
second molar affectation (8.3%).
The average time of surgical procedures was 35.2 minu-
tes on the right side and 38.9 minutes on the left, without 
statistically significant difference (t= -1.797; p=0.081). 
Average latency time for bupivacaine was 3.1 ± 1.5 mi-
nutes compared to 2 ± 1.4 minutes for articaine, with 
statistically significant difference (Z= -3.810; p=0.000) 
(Fig. 1) (Table 2).
There were higher levels of bleeding in surgery perfor-
med under anesthesia by bupivacaine, particularly during 
incision and flap elevation, being abundant in 30.6% of 
cases using bupivacaine compared to 2.8% with articai-
ne (Z= -3.664; p=0.000).
Moderate and severe intra-operative discomfort, requi-
ring additional anesthetic occurred in 16.7% of cases 
first was applied. In either case, inferior lingual alveolar 
nerve block was given with 1.8ml of anesthetic solution 
using a 27G 35mm long needle (Sofic® XL Monoprotect, 
France). This was complemented with anesthesia of the 
buccal nerve, administering 1.8ml in a second carpule 
with a 30G 25mm long needle (Sofic® XL Monoprotect, 
France). The surgical procedures were performed by 
dentists with similar levels of surgical experience, in the 
same surgery and under identical working conditions. A 
vertical releasing incision was made mesial of the se-
cond molar, lifting a mucoperiosteal flap, followed by 
ostectomy and odontosection. When the third molar had 
been extracted, suture was performed using 3/0 braided 
silk (Lorca Marin®, Murcia, Spain). As an antibiotic, 
the patient received 500mg amoxicillin orally, one ta-
blet every eight hours for one week. Anti-inflammatory 
treatment consisted of 600mg ibuprofen taken orally, 
every eight hours for three days, initiating this treatment 
when the patient experienced the first instances of pain. 
As analgesic rescue medication during the post-operati-
ve period, one 500 mg paracetamol tablet was adminis-
tered at the onset of pain. 
-Data Collection 
The reasons for extraction were registered, as well as 
the time required for the surgical intervention (in minu-
tes, timed from incision to suture). The latency time (in 
minutes from the removal of the needle to the first signs 
of loss of feeling in the lower lip) was recorded. The 
surgeon evaluated bleeding classifying it as minimum, 
normal or abundant at different points during the pro-
cedure: after incision, flap elevation, ostectomy, extrac-
tion and on completion of suture. Anesthetic quality was 
classified according to patient discomfort during surgery 
and the need (or not) to reinforce anesthesia as: no dis-
comfort, slight discomfort but not requiring additional 
anesthesia, moderate to severe discomfort needing addi-
tional anesthetic, in which case the amount of anesthesia 
required was recorded. 
Systolic and diastolic blood pressure, and cardiac rate 
were monitored using a tensiometer (OMRON® M6, 
HEM-7001-E, Paris, France) before beginning surgery, 
after anesthesia, at the moment of incision, flap eleva-
tion, ostectomy, extraction and suture. 
Duration of anesthesia in the soft tissues was timed from 
the first sign of numbness in the lower lip to complete re-
covery of feeling in the tongue and lower lip. The dura-
tion of post-operative analgesia was recorded as the time 
span from the end of the surgical procedure to ingestion 
of the first ibuprofen tablet.  
Patients noted pain levels at 2, 6, 12 and 24 hours fo-
llowing surgery on a visual analogue scale and whatever 
rescue medication they needed to take. 
-Statistical Analysis
To analyze differences between the type of anesthetic, 
the student t-test for samples was applied with quantita-
Fig. 1. Average latency time for bupivacaine and articaine.
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treated with articaine compared to 44.4% of patients 
who received bupivacaine (Z= -3.220; p=0.001). Larger 
quantities of bupivacaine were needed, with an average 
of 1.6ml per extraction, compared to 0.7ml of articaine; 
this difference was statistically significant (t = -2.572; p 
= 0.014).
Regarding haemodynamic parameters, the type of anes-
thetic solution did not influence systolic blood pressure 
(F=0.947; p=0.449), dystolic blood pressure (F=0.958; 
p=0.414) or cardiac rate (F=1.006; p=0.409) during sur-
gery (Fig. 2 and Table 2).
The duration of anesthetic effect in soft tissues was 250.3 
± 48.3 minutes with articaine and 316.5 ± 30.1 minutes 
with bupivacaine, with statistically significant differen-
ce (t= -3.239; p=0.002). The duration of post-operative 
analgesia was 203.2 ± 20.5 minutes with articaine and 
215.8 ± 15.4 minutes with bupivacaine, without signifi-
cant difference (t= -0.920; p=0.363) (Table 2).
Post-operative pain peaked at the six-hour point with 
articaine and at twelve hours after surgery with bupiva-
caine, with statistically significant difference (p=0.004) 
(Fig. 3). The average pain levels for articaine and bu-
pivacaine were 5.1 and 4.4 respectively, without sig-
nificant difference (p=0.072) (Table 2). The number of 
patients needing rescue analgesics was similar between 
the two groups (articaine n=15, bupivacaine n=19) and 
no significant difference was found for this parameter 
(Table 2) (p = 0.836).
Articaine Bupivacaine
Latency Time (minutes)* 2 ± 1.4 3.1 ± 1.5
Haemodynamics
Systolic Blood Pressure (mmHg) 124.7 124.1
Diastolic Blood Pressure (mmHg) 72.6 74.3
Cardiac Rate (ppm) 81.5 80.7
Post-Operative Pain 
2 hours 4.2 ± 0.4 3.5 ± 0.4
6 hours 5.7 ± 0.3 4.7 ± 0.4
12 hours 5.3 ± 0.3 5.1 ± 0.4
24 hours 5.2 ± 0.3 4.3 ± 0.4
Duration of anesthetic Effects on Soft Tissues (minutes)* 250.3 ± 48.3 316.5 ± 30.1
Duration of Post-Operative Analgesia (minutes) 203.2 ± 20.5 215.8 ± 15.4
Rescue Medication Consumption 42.8% 52.7%
* Statistically significant results (p<0.05).
Table 2. Objective and subjective parameters recorded in patients following surgical extraction of lower third molars 
under local anesthetic by articaine or bupivacaine. Mean averages ± standard deviation.
Fig. 2. Influence of type of anesthetic solution on systolic blood 
pressure, dystolic blood pressure or cardiac rate 
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Discussion 
The present study calculated a mean latency time of two 
minutes for articaine, results similar to those obtained 
by Malamed et al. (17), and Sierra Rebolledo et al. (18). 
For bupivacaine, latency time was 3.1 minutes, coinci-
ding with results published by Gregorio et al. (11) and 
Trullenque-Eriksson et al. (14). In other studies (15, 19-
21), latency time for bupivacaine varies between 1.9 and 
2.6 minutes, lower values than found in the present stu-
dy. The difference in latency time between articaine and 
bupivacaine could be explained by the faster activation 
of drugs with low pKa, articaine having lower pKa (7.8) 
than bupivacaine (8.1).
More bleeding was observed in interventions performed 
under anesthesia with bupivacaine, a finding that agrees 
with Buckley et al. (22) and Moore et al. (23), although 
it should be noted that these authors evaluated hemo-
rrhaging associated with periodontal surgery. However, 
the results disagree with those obtained by Gregorio et 
al. (11) and Trullenque-Eriksson y cols. (14) who obtai-
ned minimal bleeding during surgery using articaine and 
bupivacaine, both with epinephrine at 1:200,000. The 
results of the present study could be interpreted as the 
effects of a higher concentration of epinephrine in the 
articaine and the greater vasodilatory capacity of bupi-
vacaine. 
In spite of the initial administration of equal volumes 
of both local anesthetics (3.6ml), in 22% of the surgi-
cal procedures with bupivacaine the patient complained 
of discomfort and an additional volume was needed 
(1.6ml). Only 8% of cases in which articaine was used 
required an additional infiltration of the anesthetic solu-
tion (0.7ml). These results coincide with findings obtai-
ned by Gregorio et al. (11), whereby 14% of cases using 
bupivacaine needed additional anesthetic, compared to 
2% of cases using articaine. However, Trullenque-Eriks-
son et al. (14) and Sancho-Puchades et al. (15) did not 
find statistically significant differences in the need for 
additional anesthetic. 
The anesthetic used did not significantly influence blood 
pressure or heart rate during the different stages of sur-
gery. Bupivacaine was associated with higher diastolic 
blood pressure than articaine and lower systolic blood 
pressure and heart rate, but without statistically signifi-
cant differences. These findings coincide with the majo-
rity of published studies (10,24), whereby the presence 
or absence of vasoconstrictor in the anesthetic did not 
directly influence blood pressure due to the small quan-
tities involved. Fluctuations in cardiovascular function 
observed during the surgical procedure could be asso-
ciated with stress (25).
Duration of anesthesia in the soft tissues was longer with 
bupivacaine compared to articaine, with statistically sig-
nificant difference; this is similar to the results of other 
research (11, 14, 15). However, these other studies used 
articaine at 4% with 1:200,000 epinephrine. The longer 
duration of soft tissue anesthesia when bupivacaine was 
used can be explained by its greater fixation to proteins 
and vasodilatory capacity (26).
As other authors have found (13, 27-30), bupivacaine 
reduced post-operative pain more effectively compared 
to articaine, although this difference did not reach statis-
tical difference. Pain peaked later (after 12 hours) and 
with less intensity following the interventions performed 
Fig. 3. Evolution of post-operative pain with articaine and bupivacaine.
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with bupivacaine compared to articaine, for which pain 
peaked earlier (after 6 hours) and had more intensity on 
the visual analogue scale. 
Post-operative analgesia was greater for bupivacaine, 
although the difference was not significant. Other au-
thors have obtained similar results (11, 14).
In the present study, the difference in rescue analgesic 
consumption was not significant, a finding born out by 
other studies (11, 14, 15).
Overall, articaine was found to provide greater clinical 
efficacy than bupivacaine, with shorter latency time, 
less bleeding, shorter duration of soft tissue anesthesia 
and better anesthetic quality and required less additional 
anesthetic compared to bupivacaine. 
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